Irada Ibrahim-zada
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer (NCT05150652) | Irada Ibrahim-zada | 2022-02-18 |
Track Irada Ibrahim-zada automatically
Every clearance here is in the API, with alerts when new ones post.